TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/12/2022
Voltar para busca
Dado oficial do USPTO
GST GLOBAL STEM CELL TECHNOLOGY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
21/04/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
05/02/2018
Data de registro
02/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/11/2021
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
32
Localização do titular
EVERGEM, BE
Examinador
LEASER, ANDREW
Unidade examinadora
M80
Localização atual
TMO LAW OFFICE 117
Descrição da marca
The mark consists of the letters "GST" in purple atop the words "GLOBAL STEM CELL TECHNOLOGY" in grey lettering. To the left are three curved lines, two in purple and one in grey.
Titulares e representantes
Titulares
B. B. (pessoa física)
Global Stem cell Technology, naamloze vennootschap
Representantes
Clifford D. Hyra Fresh IP PLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Dietary supplements for animal and human consumption; Medical preparations for the treatment of and prevention of articular and cartilage damage and injuries; Medical preparations for the treatment of and prevention of tendon and muscle damage and injuries; Medical preparations for the treatment of and prevention of musculoskeletal disordersallergies or metabolic diseases; Pharmaceutical preparations for humans and animals in the form of injectable gelspowderstablets and fluids for preventing and treating articular and cartilage damage and injuries; Pharmaceutical preparations for humans and animals in the form of injectable gelspowderstablets and fluids for preventing and treating tendon and muscle damage and injuries; Pharmaceutical preparations for humans and animals in the form of injectable gelspowderstablets and fluids for preventing and treating musculoskeletal disordersallergies or metabolic diseases; Stem cells for veterinary use; Surgical implants comprising living tissue; Veterinary preparations for the treatment and prevention of articular and cartilage damage and injuries; Veterinary preparations for the treatment and prevention of tendon and muscle damage and injuries; Veterinary preparations for the treatment and prevention of musculoskeletal disordersallergies or metabolic diseases; Vitamin preparations
Classe 42
Laboratory analysis in the field of biotechnology; Laboratory research in the field of biotechnology; Medical laboratory services; Providing scientific research information in the field of stem cellsstem cell therapy and biotechnology; Research and development and consultation related thereto in the field of stem cells and stem cell therapy; Research and development in the field of biotechnology; Scientific laboratory services; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics
Classe 44
Medical diagnosis and treatment of disorders of the human or animal body; Medical servicesthe isolationcollection and banking of stem cells; Providing medical information to patientsdoctors and veterinarians in the form of reports in the field of stem cellsstem cell therapy and biotechnology
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/09/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/05/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
22/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/08/2021
PUBO
PUBLISHED FOR OPPOSITION
17/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/07/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/07/2021
ALIE
ASSIGNED TO LIE
12/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/07/2021
OTHE
CASE RETURNED TO EXAMINATION
09/07/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/07/2021
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
24/06/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
24/06/2021
APET
ASSIGNED TO PETITION STAFF
21/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/06/2021
EX5G
SOU EXTENSION 5 GRANTED
01/06/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/05/2021
EXT5
SOU EXTENSION 5 FILED
19/05/2021
EEXT
SOU TEAS EXTENSION RECEIVED
19/05/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
19/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/12/2020
EX4G
SOU EXTENSION 4 GRANTED
11/12/2020
EXT4
SOU EXTENSION 4 FILED
11/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/08/2020
EX3G
SOU EXTENSION 3 GRANTED
10/08/2020
EXT3
SOU EXTENSION 3 FILED
10/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/01/2020
EX2G
SOU EXTENSION 2 GRANTED
22/01/2020
EXT2
SOU EXTENSION 2 FILED
22/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
22/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/08/2019
EX1G
SOU EXTENSION 1 GRANTED
30/07/2019
EXT1
SOU EXTENSION 1 FILED
30/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
30/07/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/02/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
23/12/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/08/2018
PUBO
PUBLISHED FOR OPPOSITION
14/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/05/2018
GNRT
NON-FINAL ACTION E-MAILED
22/05/2018
CNRT
NON-FINAL ACTION WRITTEN
22/05/2018
DOCK
ASSIGNED TO EXAMINER
16/05/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
14/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/02/2018
NWAP
NEW APPLICATION ENTERED
08/02/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GST GLOBAL STEM CELL TECHNOLOGY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.